The Chicago Entrepreneur

Cannabis stocks rally after AP reports DEA will propose reclassifying drug as Schedule III

AdvisorShares Pure U.S. Cannabis ETF jumps 28%.

Previous post FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic
Next post The ‘Magnificent Seven’ aren’t seven. Or magnificent.